Viking Therapeutics, Inc. (VKTX)

32.22 -1.87 (-5.49%) USD  |  NASDAQ  |  Jan 23, 16:00
32.22 0.00 (0.00%) After-Hours: 20:00
More

Viking Therapeutics Non-Current Portion of LTD and Capital Lease Obligation (Annual Per Share)

Non-Current Portion of LTD and Capital Lease Obligation (Annual Per Share) Chart

View Non-Current Portion of LTD and Capital Lease Obligation (Annual Per Share) for VKTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Non-Current Portion of LTD and Capital Lease Obligation (Annual Per Share) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Non-Current Portion of LTD and Capital Lease Obligation (Annual Per Share) Range, Past 5 Years

View Non-Current Portion of LTD and Capital Lease Obligation (Annual Per Share) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Non-Current Portion of LTD and Capital Lease Obligation (Annual Per Share) Benchmarks

View Non-Current Portion of LTD and Capital Lease Obligation (Annual Per Share) Benchmarks
Start Trial
Eli Lilly & Co. Upgrade
Pfizer Inc. Upgrade
Amgen, Inc. Upgrade
Altimmune, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade